Evidence map›Paper›PMID 26545722›Full record

ArticleBMC cancer2015

Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.

Rakesh Bam, Sharmin Khan, Wen Ling, Shelton S Randal, Xin Li, Bart Barlogie, Ricky Edmondson, Shmuel Yaccoby

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The Open Challenge ofFrontiers in bioengineering and biotechnology · 2020
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rakesh BamMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. rakeshbam@gmail.com.
Sharmin KhanMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. SKhan@uams.edu.
Wen LingMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. WLing@uams.edu.
Shelton S RandalMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. SheltonRandalS@uams.edu.
Xin LiMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Lixin@uams.edu.
Bart BarlogieMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. blackbarlogie@gmail.com.
Ricky EdmondsonMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. RDEdmondson@uams.edu.
Shmuel YaccobyMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. yaccobyshmuel@uams.edu.
University of Arkansas for Medical Sciences · US

Funding

Tumor Cell-Microenvironment Interactions in the Molecular Pathogenesis of MultiplP01CA055819 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI BELLAMY, WILLIAM T · 1993 to 2013
$49.7M
Myeloma-Microenvironment Interaction DynamicsR01CA093897 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI YACCOBY, SHMUEL · 2002 to 2012
$2.5M
NCI NIH HHS CA093897NCI NIH HHS CA55819NCI NIH HHS P01 CA055819NCI NIH HHS R01 CA093897
6 · The paper itself

Abstract

backgroundHuman primary myeloma (MM) cells do not survive in culture; current in vitro and in vivo systems for growing these cells are limited to coculture with a specific bone marrow (BM) cell type or growth in an immunodeficient animal model. The purpose of the study is to establish an interactive healthy donor whole BM based culture system capable of maintaining prolonged survival of primary MM cells. This normal BM (NBM) coculture system is different from using autologous BM that is already affected by the disease.

methodsWhole BM from healthy donors was cultured in medium supplemented with BM serum from MM patients for 7 days, followed by 7 days of coculture with CD138-selected primary MM cells or MM cell lines. MM cells in the coculture were quantified using flow cytometry or bioluminescence of luciferase-expressing MM cells. T-cell cytokine array and proteomics were performed to identify secreted factors.

resultsNBM is composed of adherent and nonadherent compartments containing typical hematopoietic and mesenchymal cells. MM cells, or a subset of MM cells, from all examined cases survived and grew in this system, regardless of the MM cells' molecular risk or subtype, and growth was comparable to coculture with individual stromal cell types. Adherent and nonadherent compartments supported MM growth, and this support required patient serum for optimal growth. Increased levels of MM growth factors IL-6 and IL-10 along with MM clinical markers B2M and LDHA were detected in supernatants from the NBM coculture than from the BM cultured alone. Levels of extracellular matrix factors (e.g., MMP1, HMCN1, COL3A1, ACAN) and immunomodulatory factors (e.g., IFI16, LILRB4, PTPN6, AZGP1) were changed in the coculture system. The NBM system protected MM cells from dexamethasone but not bortezomib, and effects of lenalidomide varied.

conclusionsThe NBM system demonstrates the ability of primary MM plasma cells to interact with and to survive in coculture with healthy adult BM. This model is suitable for studying MM-microenvironment interactions, particularly at the early stage of engagement in new BM niches, and for characterizing MM cell subpopulations capable of long-term survival through secretion of extracellular matrix and immune-related factors.

Indexed as

Cell CommunicationCoculture TechniquesAntigens, CDAntineoplastic AgentsBone Marrow CellsCell LineCell SurvivalCytokinesHumansImmunohistochemistryImmunophenotypingMesenchymal Stem CellsMultiple MyelomaOsteoclastsProteomeProteomicsAntigens, CDAntineoplastic AgentsCytokinesProteome

Identifiers

PMID26545722
PMCPMC4636897
OpenAlexW2266749803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.